26: Elective induction of labor at 39 weeks versus expectant management in low-risk multiparous women

The ARRIVE Trial demonstrated lower cesarean delivery rates, decreased hypertensive disorders of pregnancy and potentially improved perinatal outcomes in low-risk nulliparous women undergoing elective induction of labor (eIOL) at 39 weeks as compared to expectant management (EM). Our objective was to compare maternal and neonatal outcomes between eIOL and EM in low-risk multiparous women.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Oral Concurrent 2 Source Type: research